news Potent nanoparticle may help improve vaccines for HIV and other diseases 7 December 2021 | By Anna Begley (Drug Target Review) The new nanoparticle adjuvant improved antibody production following vaccination against HIV, diphtheria and influenza in mouse models.
news T cells target broad range of SARS-CoV-2 epitopes, study shows 29 January 2021 | By Victoria Rees (Drug Target Review) A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
news Researchers work to create a COVID-19 viral epitope map 13 March 2020 | By Hannah Balfour (Drug Target Review) The team used data from SARS-CoV to identify possible viral epitopes that vaccines could include to stimulate an immune response.